Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data

Autor: Cécile Rouzier, Jean Amiel, Jean-François Michiels, Laure Valério, Juliette Haudebourg, Florence Pedeutour, Xavier Carpentier
Přispěvatelé: Laboratory of Solid Tumors Genetics, Nice University Hospital, Institut de signalisation, biologie du développement et cancer (ISBDC), Centre National de la Recherche Scientifique (CNRS)-Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA), Laboratoire d'Anatomo-Pathologie, Hôpital Pasteur [Nice] (CHU), Laboratoire d'Urologie, Department of Public Health, Hôpital l'Archet
Rok vydání: 2008
Předmět:
Male
Cancer Research
Oncogene Proteins
Fusion

Oncogene Proteins
MESH: Paraffin Embedding
Chromosomal translocation
MESH: Formaldehyde
law.invention
Fusion gene
MESH: Aged
80 and over

0302 clinical medicine
law
Prostate
MESH: Reverse Transcriptase Polymerase Chain Reaction
MESH: Fixatives
MESH: Serine Endopeptidases
Polymerase chain reaction
MESH: Aged
Aged
80 and over

0303 health sciences
MESH: Middle Aged
Paraffin Embedding
Reverse Transcriptase Polymerase Chain Reaction
Serine Endopeptidases
MESH: Transcription Factors
Middle Aged
3. Good health
DNA-Binding Proteins
medicine.anatomical_structure
030220 oncology & carcinogenesis
Adenocarcinoma
Adenovirus E1A Proteins
PCA3
MESH: Proto-Oncogene Proteins c-ets
[SDV.CAN]Life Sciences [q-bio]/Cancer
Biology
Fixatives
03 medical and health sciences
Antigen
Formaldehyde
Proto-Oncogene Proteins
Genetics
medicine
Humans
Molecular Biology
Aged
Retrospective Studies
030304 developmental biology
MESH: Humans
Proto-Oncogene Proteins c-ets
MESH: Adenocarcinoma
Prostatic Neoplasms
MESH: Retrospective Studies
medicine.disease
MESH: Adenovirus E1A Proteins
MESH: Male
MESH: Proto-Oncogene Proteins
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
MESH: Prostatic Neoplasms
Immunology
Cancer research
Feasibility Studies
MESH: Feasibility Studies
MESH: DNA-Binding Proteins
MESH: Oncogene Proteins
Fusion

Transcription Factors
Zdroj: Cancer Genetics and Cytogenetics
Cancer Genetics and Cytogenetics, Elsevier, 2008, 183 (1), pp.21-7. ⟨10.1016/j.cancergencyto.2008.01.021⟩
ISSN: 0165-4608
DOI: 10.1016/j.cancergencyto.2008.01.021
Popis: The recent identification of fusion genes involving ETS family members in human prostate adenocarcinoma has confirmed the hypothesis that recurrent specific aberrations such as fusion genes may be as frequent in epithelial tumors as they are in leukemias and sarcomas. However, reciprocal translocations with fusion genes are often not detectable in carcinomas by conventional karyotyping because of additional complex chromosomal abnormalities. We retrospectively analyzed a large series of formalin-fixed, paraffin-embedded samples including 55 prostate carcinomas and 11 benign prostate tumors. We identified the fusion gene TMPRSS2-ERG by reverse-transcriptase polymerase chain reaction (RT-PCR) in 40/55 carcinomas (72%). Our study demonstrates that the detection of ETS fusion gene by RT-PCR is feasible on formalin-fixed and paraffin-embedded samples. No significant association between the presence of the fusion gene and any clinical feature, such as preoperative serum prostate-specific antigen (PSA) level (PSA>20 or PSA< or =20), pTNM stage including capsule invasion, seminal vesicle invasion, and lymph nodes metastases, or recurrence was observed in our series.
Databáze: OpenAIRE